116 related articles for article (PubMed ID: 10075167)
1. The use of Toxorhynchites splendens for identification and quantitation of serotypes contained in the tetravalent live attenuated dengue vaccine.
Jirakanjanakit N; Khin MM; Yoksan S; Bhamarapravati N
Vaccine; 1999 Feb; 17(6):597-601. PubMed ID: 10075167
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti.
Jirakanjanakit N; Khin MM; Yoksan S; Bhamarapravati N
Am J Trop Med Hyg; 1999 Oct; 61(4):672-6. PubMed ID: 10548309
[TBL] [Abstract][Full Text] [Related]
3. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.
Sun W; Edelman R; Kanesa-Thasan N; Eckels KH; Putnak JR; King AD; Houng HS; Tang D; Scherer JM; Hoke CH; Innis BL
Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):24-31. PubMed ID: 14740952
[TBL] [Abstract][Full Text] [Related]
5. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.
Troyer JM; Hanley KA; Whitehead SS; Strickman D; Karron RA; Durbin AP; Murphy BR
Am J Trop Med Hyg; 2001 Nov; 65(5):414-9. PubMed ID: 11716092
[TBL] [Abstract][Full Text] [Related]
6. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
[TBL] [Abstract][Full Text] [Related]
7. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.
Whitehead SS; Falgout B; Hanley KA; Blaney JE; Markoff L; Murphy BR
J Virol; 2003 Jan; 77(2):1653-7. PubMed ID: 12502885
[TBL] [Abstract][Full Text] [Related]
8. Live attenuated tetravalent dengue vaccine.
Bhamarapravati N; Sutee Y
Vaccine; 2000 May; 18 Suppl 2():44-7. PubMed ID: 10821973
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico.
Dayan GH; Galán-Herrera JF; Forrat R; Zambrano B; Bouckenooghe A; Harenberg A; Guy B; Lang J
Hum Vaccin Immunother; 2014; 10(10):2853-63. PubMed ID: 25483647
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.
Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chokejindachai W; Jagsudee A; Saluzzo JF; Bhamarapravati N
Am J Trop Med Hyg; 2002 Mar; 66(3):264-72. PubMed ID: 12139219
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.
Kanesa-thasan N; Sun W; Kim-Ahn G; Van Albert S; Putnak JR; King A; Raengsakulsrach B; Christ-Schmidt H; Gilson K; Zahradnik JM; Vaughn DW; Innis BL; Saluzzo JF; Hoke CH
Vaccine; 2001 Apr; 19(23-24):3179-88. PubMed ID: 11312014
[TBL] [Abstract][Full Text] [Related]
12. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes.
Khanam S; Rajendra P; Khanna N; Swaminathan S
BMC Biotechnol; 2007 Feb; 7():10. PubMed ID: 17302980
[TBL] [Abstract][Full Text] [Related]
13. Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate.
Anderson KB; Gibbons RV; Edelman R; Eckels KH; Putnak RJ; Innis BL; Sun W
J Infect Dis; 2011 Aug; 204(3):442-50. PubMed ID: 21742844
[TBL] [Abstract][Full Text] [Related]
14. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.
Huang CY; Butrapet S; Tsuchiya KR; Bhamarapravati N; Gubler DJ; Kinney RM
J Virol; 2003 Nov; 77(21):11436-47. PubMed ID: 14557629
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
Kitchener S; Nissen M; Nasveld P; Forrat R; Yoksan S; Lang J; Saluzzo JF
Vaccine; 2006 Feb; 24(9):1238-41. PubMed ID: 16213632
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
[TBL] [Abstract][Full Text] [Related]
17. Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.
Liu Y; Zhou J; Yu Z; Fang D; Fu C; Zhu X; He Z; Yan H; Jiang L
BMC Microbiol; 2014 Dec; 14():233. PubMed ID: 25520151
[TBL] [Abstract][Full Text] [Related]
18. Development of a fluorescent focus identification assay using serotype-specific monoclonal antibodies for detection and quantitation of rotaviruses in a tetravalent rotavirus vaccine.
Yang DP; Goldberg KM; Ma XD; Magargle W; Rappaport R
Clin Diagn Lab Immunol; 1998 Nov; 5(6):780-3. PubMed ID: 9801334
[TBL] [Abstract][Full Text] [Related]
19. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
Blaney JE; Matro JM; Murphy BR; Whitehead SS
J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
[TBL] [Abstract][Full Text] [Related]
20. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
